The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Corcept Therapeutics Inc shares valued at $1,601,526 were sold by Guyer William on Dec 02 ’25. At $80.08 per share, Guyer William sold 20,000 shares. The insider’s holdings dropped to 1,235 shares worth approximately $0.1 million following the completion of this transaction.
Also, Maduck Sean sold 20,000 shares, netting a total of over 1,590,490 in proceeds. Following the sale of shares at $79.52 each, the insider now holds 7,904 shares.
Before that, Lyon Joseph Douglas had sold 5,000 shares from its account. In a trade valued at $397,632, the insider traded Corcept Therapeutics Inc shares for $79.53 each. Upon closing the transaction, the insider’s holdings decreased to 5,000 shares, worth approximately $0.85 million.
As published in their initiating research note from UBS on December 16, 2025, Corcept Therapeutics Inc [CORT] has been a Neutral. Analysts at Wolfe Research started covering the stock with ‘”a Peer perform”‘ outlook in a report released in mid November. As of November 06, 2023, Truist has increased its “Hold” rating to a “Buy” for CORT. Earlier on April 11, 2023, SVB Securities initiated its rating. Their recommendation was “a Market perform” for CORT stock.
Analyzing CORT Stock Performance
On last trading session, Corcept Therapeutics Inc [NASDAQ: CORT] rose 1.43% to $82.28. The stock’s lowest price that day was $79.02, but it reached a high of $82.98 in the same session. During the last five days, there has been a drop of approximately -3.55%. Over the course of the year, Corcept Therapeutics Inc shares have jumped approximately 48.52%. Shares of the company reached a 52-week high of $117.33 on 03/31/25 and a 52-week low of $49.00 on 01/13/25.
Support And Resistance Levels for Corcept Therapeutics Inc (CORT)
According to the 24-hour chart, there is a support level at 79.87, which, if violated, would cause prices to drop to 77.47. In the upper region, resistance lies at 83.83. The next price resistance is at 85.39. RSI (Relative Strength Index) is 52.08 on the 14-day chart, showing neutral technical sentiment.
Is Corcept Therapeutics Inc subject to short interest?
Stocks of Corcept Therapeutics Inc saw a sharp steep in short interest on 2025-11-28 dropping by -0.7 million shares to 10.34 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 11.05 million shares. A decline of -6.82% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 16.34 of the overall float, the days-to-cover ratio (short ratio) decline to 16.34.
Which companies own the most shares of Corcept Therapeutics Inc (CORT)?
In terms of Corcept Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 117.5 in the next 12 months, up nearly 44.85% from the previous closing price of $81.12. Analysts anticipate Corcept Therapeutics Inc stock to reach 140 by 2025, with the lowest price target being 95. In spite of this, 4 analysts ranked Corcept Therapeutics Inc stock as Buy at the end of 2025. On April 04, 2023, Piper Sandler assigned a price target of “an Overweight” to the stock and initiated coverage with a $27.
